ESMO Congress 2019: Scientific Articles & Press Releases

Interested in what happened during the ESMO Congress 2019?

Read all our news here

Date Title Topic
30 Sep 2019 Adding Atezolizumab to Front-Line Platinum-Based Chemotherapy Improves Progression-Free Survival in mUC Genitourinary cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
30 Sep 2019 Olaparib Outperforms Enzalutamide or Abiraterone Acetate in Men with mCRPC and HRR Alterations Genitourinary cancers - Personalised medicine - Anticancer agents & Biologic therapy
30 Sep 2019 Ivosidenib Provides Prolonged Progression-Free Survival in Patients with Cholangiocarcinoma and IDH1 Mutation Gastrointestinal cancers - Personalised medicine - Anticancer agents & Biologic therapy
30 Sep 2019 Adding immunotherapy to chemotherapy prolongs progression free survival in bladder cancer [ESMO 2019 Press Release] Genitourinary cancers
30 Sep 2019 Targeted Therapy Slows Progression of Advanced Prostate Cancer [ESMO 2019 Press Release] Genitourinary cancers
30 Sep 2019 First Targeted Therapy for Cholangiocarcinoma Shows Clinical Benefit in Phase III Trial [ESMO 2019 Press Release] Gastrointestinal cancers
30 Sep 2019 Efficacy Differences Are Observed According to Patients’ Sex with Immunotherapy in Advanced Solid Tumours Cancer Immunology and Immunotherapy
30 Sep 2019 First Report of Head and Neck Squamous Cell Carcinoma Treatment Individualised by Geriatric Assessment Head and neck cancers - Cancer in Special Situations / Population
30 Sep 2019 Lenvatinib Provides Encouraging Responses in Advanced or Metastatic Thymic Carcinoma Endocrine and neuroendocrine tumours - Anticancer agents & Biologic therapy
30 Sep 2019 Mesothelioma Trial Suggests Immunotherapy as an Alternative to Chemotherapy [ESMO 2019 Press Release] Lung and other thoracic tumours
30 Sep 2019 Blood Test Can Replace Invasive Biopsy for More Patients with Lung Cancer [ESMO 2019 Press Release] Lung and other thoracic tumours
29 Sep 2019 Significant PFS Benefit Observed with Veliparib plus Carboplatin and Paclitaxel in Patients with Advanced HER2-negative Breast Cancer and BRCA1/2 Mutations Breast cancer - Anticancer agents & Biologic therapy
29 Sep 2019 Adding Pembrolizumab to Neoadjuvant Chemotherapy Improves Outcome in Early TNBC Breast cancer - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
29 Sep 2019 Final FLAURA Results Demonstrate Overall Survival Benefit with Osimertinib Over TKIs in Advanced NSCLC Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
29 Sep 2019 LOXO-292 Demonstrates Promising Anti-Tumour Activity in RET-Altered Thyroid Cancer Endocrine and neuroendocrine tumours - Personalised medicine - Anticancer agents & Biologic therapy